• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIV-1逆转录酶中两个保守序列基序的突变分析。

Mutational analysis of two conserved sequence motifs in HIV-1 reverse transcriptase.

作者信息

Lowe D M, Parmar V, Kemp S D, Larder B A

机构信息

Department of Molecular Sciences, Wellcome Research Laboratories, Beckenham, Kent, U.K.

出版信息

FEBS Lett. 1991 May 6;282(2):231-4. doi: 10.1016/0014-5793(91)80484-k.

DOI:10.1016/0014-5793(91)80484-k
PMID:1709876
Abstract

Two conserved sequence motifs, occurring in HIV-1 reverse transcriptase at residues 110-116 and 183-190, have been studied using site-directed mutagenesis of the cloned gene. In particular, aspartates at positions 185 and 186 have each been mutated to either asparagine or glutamate. The resulting mutant proteins were catalytically inactive but still able to bind the template-primer complex, poly rA-oligo dT. Other mutations in these regions resulted in reduced reverse trascriptase activity but the mutation of tyrosine-183 to serine caused a significant increase in the Km for dTTP and the Ki for inhibition by 3'-azidothymidine-triphosphate, 2',3'-dideoxythymidine-triphosphate and phosphonoformic acid.

摘要

利用克隆基因的定点诱变技术,对在HIV-1逆转录酶中位于110-116位和183-190位的两个保守序列基序进行了研究。特别是,185位和186位的天冬氨酸分别被突变为天冬酰胺或谷氨酸。所产生的突变蛋白没有催化活性,但仍能够结合模板-引物复合物,即聚rA-寡聚dT。这些区域的其他突变导致逆转录酶活性降低,但将183位的酪氨酸突变为丝氨酸会使dTTP的Km以及3'-叠氮胸苷三磷酸、2',3'-双脱氧胸苷三磷酸和膦甲酸抑制作用的Ki显著增加。

相似文献

1
Mutational analysis of two conserved sequence motifs in HIV-1 reverse transcriptase.HIV-1逆转录酶中两个保守序列基序的突变分析。
FEBS Lett. 1991 May 6;282(2):231-4. doi: 10.1016/0014-5793(91)80484-k.
2
Human immunodeficiency virus reverse transcriptase. Substrate and inhibitor kinetics with thymidine 5'-triphosphate and 3'-azido-3'-deoxythymidine 5'-triphosphate.人类免疫缺陷病毒逆转录酶。与胸苷5'-三磷酸和3'-叠氮-3'-脱氧胸苷5'-三磷酸的底物及抑制剂动力学。
J Biol Chem. 1990 Nov 25;265(33):20302-7.
3
Reverse transcriptases from human immunodeficiency virus type 1 (HIV-1), HIV-2, and simian immunodeficiency virus (SIVMAC) are susceptible to inhibition by foscarnet and 3'-azido-3'-deoxythymidine triphosphate.来自1型人类免疫缺陷病毒(HIV-1)、HIV-2和猴免疫缺陷病毒(SIVMAC)的逆转录酶对膦甲酸钠和3'-叠氮-3'-脱氧胸苷三磷酸敏感,易受其抑制。
Antimicrob Agents Chemother. 1988 Nov;32(11):1733-4. doi: 10.1128/AAC.32.11.1733.
4
Sensitivity of HIV-1 reverse transcriptase and its mutants to inhibition by azidothymidine triphosphate.人类免疫缺陷病毒1型逆转录酶及其突变体对叠氮胸苷三磷酸抑制作用的敏感性。
Biochemistry. 1994 Mar 1;33(8):2113-20. doi: 10.1021/bi00174a018.
5
Enzymatic characterization of human immunodeficiency virus type 1 reverse transcriptase resistant to multiple 2',3'-dideoxynucleoside 5'-triphosphates.对多种2',3'-双脱氧核苷5'-三磷酸具有抗性的1型人类免疫缺陷病毒逆转录酶的酶学特性
J Biol Chem. 1995 Oct 6;270(40):23605-11. doi: 10.1074/jbc.270.40.23605.
6
Interactions of the HIV-1 reverse transcriptase 'AZT-resistant' mutant with substrates and AZT-TP.
FEBS Lett. 1993 Jul 5;325(3):237-41. doi: 10.1016/0014-5793(93)81080-j.
7
3'-Azido-3',5'-dideoxythymidine-5'-methylphosphonic acid diphosphate: synthesis and HIV-1 reverse transcriptase inhibition.
J Med Chem. 1992 Aug 21;35(17):3192-6. doi: 10.1021/jm00095a014.
8
The observed inhibitory potency of 3'-azido-3'-deoxythymidine 5'-triphosphate for HIV-1 reverse transcriptase depends on the length of the poly(rA) region of the template.
Biochemistry. 1992 Feb 11;31(5):1375-9. doi: 10.1021/bi00120a013.
9
The characterization of EIAV reverse transcriptase and its inhibition by 5'-triphosphates of 2'-deoxyuridine analogs, PFA and PAA.马传染性贫血病毒逆转录酶的特性及其被2'-脱氧尿苷类似物、PFA和PAA的5'-三磷酸抑制的情况。
Proc Chin Acad Med Sci Peking Union Med Coll. 1990;5(3):130-4.
10
HIV-1 reverse transcriptase inhibition by a dipyridodiazepinone derivative: BI-RG-587.二吡啶并二氮杂䓬酮衍生物BI-RG-587对HIV-1逆转录酶的抑制作用
Biochem Pharmacol. 1992 Mar 17;43(6):1371-6. doi: 10.1016/0006-2952(92)90515-k.

引用本文的文献

1
Structural basis of deoxynucleotide addition by HIV-1 RT during reverse transcription.HIV-1逆转录酶在逆转录过程中添加脱氧核苷酸的结构基础。
Nat Commun. 2024 Dec 4;15(1):10553. doi: 10.1038/s41467-024-54618-y.
2
Mechanistic Interplay between HIV-1 Reverse Transcriptase Enzyme Kinetics and Host SAMHD1 Protein: Viral Myeloid-Cell Tropism and Genomic Mutagenesis.HIV-1 逆转录酶酶动力学与宿主 SAMHD1 蛋白之间的机制相互作用:病毒的髓系细胞嗜性和基因组诱变。
Viruses. 2022 Jul 26;14(8):1622. doi: 10.3390/v14081622.
3
Fusion to Flaviviral Leader Peptide Targets HIV-1 Reverse Transcriptase for Secretion and Reduces Its Enzymatic Activity and Ability to Induce Oxidative Stress but Has No Major Effects on Its Immunogenic Performance in DNA-Immunized Mice.
融合到黄病毒先导肽靶向 HIV-1 逆转录酶进行分泌,降低其酶活性和诱导氧化应激的能力,但对 DNA 免疫小鼠中的免疫原性性能没有重大影响。
J Immunol Res. 2017;2017:7407136. doi: 10.1155/2017/7407136. Epub 2017 Jun 22.
4
Evaluation of heterologous vaginal SHIV SF162p4 infection following vaccination with a polyvalent Clade B virus-like particle vaccine.用多价B亚型病毒样颗粒疫苗接种后对异源阴道SHIV SF162p4感染的评估。
AIDS Res Hum Retroviruses. 2012 Sep;28(9):1063-72. doi: 10.1089/AID.2011.0351. Epub 2012 Mar 21.
5
The impact of molecular manipulation in residue 114 of human immunodeficiency virus type-1 reverse transcriptase on dNTP substrate binding and viral replication.人类免疫缺陷病毒 1 型逆转录酶第 114 位残基的分子操作对 dNTP 底物结合和病毒复制的影响。
Virology. 2012 Jan 20;422(2):393-401. doi: 10.1016/j.virol.2011.11.004. Epub 2011 Dec 5.
6
A phase I trial of preventive HIV vaccination with heterologous poxviral-vectors containing matching HIV-1 inserts in healthy HIV-uninfected subjects.一项在健康 HIV 未感染者中使用含有匹配 HIV-1 插入物的异源痘病毒载体进行预防性 HIV 疫苗接种的 I 期试验。
Vaccine. 2011 Feb 24;29(10):1948-58. doi: 10.1016/j.vaccine.2010.12.104. Epub 2011 Jan 7.
7
The Role of Nucleotide Excision by Reverse Transcriptase in HIV Drug Resistance.逆转录酶核苷酸切除在HIV耐药性中的作用
Viruses. 2010 Jan 28;2(2):372-394. doi: 10.3390/v2020372.
8
HIV-1 lentiviral vector immunogenicity is mediated by Toll-like receptor 3 (TLR3) and TLR7.HIV-1 慢病毒载体的免疫原性是由 Toll 样受体 3(TLR3)和 TLR7 介导的。
J Virol. 2010 Jun;84(11):5627-36. doi: 10.1128/JVI.00014-10. Epub 2010 Mar 17.
9
Human immunodeficiency virus-like particles with consensus envelopes elicited broader cell-mediated peripheral and mucosal immune responses than polyvalent and monovalent Env vaccines.具有共有包膜的人免疫缺陷病毒样颗粒比多价和单价Env疫苗引发更广泛的细胞介导的外周和黏膜免疫反应。
Vaccine. 2009 Jul 9;27(32):4337-49. doi: 10.1016/j.vaccine.2009.04.032. Epub 2009 May 3.
10
Capsid processing requirements for abrogation of Fv1 and Ref1 restriction.Fv1和Ref1限制消除的衣壳加工要求
J Virol. 2005 Aug;79(16):10571-7. doi: 10.1128/JVI.79.16.10571-10577.2005.